CCL22 and esophageal squamous cell carcinoma: Unexpectedly, the reductions in ESCC invasion (Fig. 4F) and growth (Fig. 4G) upon VS-6063 treatment were more statistically significant in ESCC cells incubated with CCL22 or pol-TAMs than in ESCC cells cultured alone.